AQP4 and nervous system disorder: In our series of patients with NMO and related disorders, we show that antibodies to the AQP4 water channel are present in 63% of patients with NMO or at high risk of the disease, but are virtually absent in patients with MS and other inflammatory and noninflammatory neurological diseases (5/217), as well as in patients with rheumatological diseases and in healthy controls (0/74).